The analysis of AI-related patents in healthcare
 reveals significant advancements in computational 
 drug discovery methods. Recent trends show increased use
  of machine learning algorithms for lead optimization and drug 
  structure prediction.
   Personalized medicine is gaining traction with AI
    tools integrating genetic data into treatment plans,
     enhancing precision. Regulatory compliance remains a 
     challenge, particularly with complex approvals.
Emerging sub-technologies include AI-driven genomics tools
 that are being explored for personalized therapies.